INTRODUCTION
Many experimental and clinical solid tumors are known to exhibit poor oxygenation l -3 and high interstitial fluid pressure 4 , 5 (IFP) in comparison to normal surrounding tissues. Oxygenation and IFP in addition to abnormal blood flow influence the response of tumors to various therapies and are also important for development and progression of malignant growth. I -5 Hydralazine (HYZ) is an arteriolar vasodilating drug which is used for treatment of hypertension in humans. 6 HYZ can decrease both tumor blood flow 7 -1O and tumor IFP. 9 , II These two changes may have opposite effects on drug delivery and oxygenation in tumors. In our study we evaluated the effect of HYZ on blood flow, oxygenation, and IFP in a murine tumor model. Oxygenation was measured by a relatively new method which has recently become available, the OxyLite system. 12 ,13 2. MATERIALS AND METHODS
Tumor model and anesthesia
The study was performed on solid subcutaneous SA-I fibrosarcoma tumors (Jackson Lab., Bar Harbor, U.S.A.) growing dorsolaterally in the right flank of AlJ mice (Rudjer Boskovic Inst., Zagreb, Croatia). Tumors were inoculated by injection of 5x10 5 viable SA-I cells. Measurements were performed 8-10 days after inoculation when the tumors reached a volume of approximately 100 mm 3 • Mice were anesthetized during experiments by isoflurane (concentration l.7%) delivered via a miniature face mask in a mixture of O2 and N20. Physiological temperature of mice was maintained by a regulated heating pad. At the end of experiments the mice were euthanized under anesthesia by cervical 
Measurement methods
Relative blood flow in tumors was measured by laser Doppler flowmetry (LDF). A two-channel instrument OxyFlo (Oxford Optronix, U.K.) was used in our study with invasive bare optical fiber sensors (diameter 0.2 mm).
Partial pressure of oxygen (POJJ in tumors was measured by a novel luminescencebased fiber-optic technique. This method employs a ruthenium luminophore, which is incorporated in a silicone cap fixed to the tip of a fiber-optic sensor. 12. 13 Pulses of blue light carried via the fiber excite pulsatile fluorescence of the luminophore. The life-time of this fluorescence is inversely proportional to local pOz in tissue in contact with the probe tip.
The advantage of this method over the well established polarographic oximetry is that the fiber-optic p02 sensor does not consume oxygen and should therefore enable continuous monitoring of pOz. A two-channel instrument OxyLite with combined pOz and temperature sensors (diameter 0.3 mm) were used in our study (Oxford Optronix, u.K.) .
Interstitial fluid pressure (IFP) in tumors was measured by the so-called "wick-inneedle" technique. II. 14 The system used in our study consisted of needle probes (diameter 0.5 mm), TSDI04A pressure transducers, a DA100A amplifier, and an MPIOO data acquisition unit (Biopac Systems, U.S.A.).
All probes were inserted into tissue approximately 5 minutes after the start of anesthesia in mice. The IFP probe was inserted into tumor from the caudal side. Both pOz and both LDF probes were inserted into tumor from the cranial side. All probes were slightly withdrawn after insertion to minimize tissue compression.
Hydralazine treatment
Hydralazine (Sigma Chemical, U.S.A.) was dissolved in sterile physiological saline and injected i. V. at a dose of 2.5 mg/kg of mouse weight. Control mice were injected with physiological saline only. Injections were made during measurements and only if all recorded signals had been stable for at least 10 minutes prior to injection.
RESULTS AND DISCUSSION
After injection of hydralazine (HYZ) blood flow started to decrease in all measurement locations. On average blood flow decreased by 50% within 5-10 minutes (Fig. la) . No change was observed in control tumors. The results are in good agreement with the previously documented effect ofHYZ on tumor blood flow. 7 -IO Two distinct types of p02 signals were observed after insertion of a probe into tumor (Fig. 2) . First, pOz decreased within one minute to near zero level in all cases (the decrease phase). In about 1/3 of measurements this near-to-zero p02 (the zero p02 phase) was maintained during the whole period of observation (the type II signals). In the remaining 2/3 of measurements (the type I signals) p02 started to increase after 5-20 minutes (the increase phase) and finally stabilized at a new level (the plateau phase) 20-
